480 ARSENAL WAY, SUITE 100, WATERTOWN, MA
Market cap: $51.1M (2/08/2026)
Price: $1.62
Investor Presentation
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data
Earnings Release
Shareholder votes
Reports First Quarter 2025 Financial Results and Business Highlights
Annual Report to Security Holders
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload
Definitive Revised Proxy Statement
SEC Staff Correspondence